Sarah Chamberlain is the Graphic & Multimedia Designer for the Unit and we are very proud to announce that she has won the runner-up prize for ELFIN: Save the date in the catergory Research Poster: Innovative Design award at the OxTALENT2018 awards.
The 10-item Edingurgh Postnatal Depression Scale (EPDS), which relies on self-report, is an established screening tool for monitoring depressive symptoms in the postnatal period. It is usually used as a single score, with variable cut-offs and has been used in longitudinal research studies and in many cross sectional studies on maternal wellbeing, as well as in clinical practice.
Inconsistent findings and replication difficulties have limited use of the EPDS as a multi-dimensional tool.
A newly published study by Maggie Redshaw and Colin Martin focuses on the factor structure and different models that have been reported in identifying possible dimensions within the scale. Participants were two samples of postpartum women in England assessed at three months and six months using 2016 Maternity Survey data. The findings indicate a multidimensional measure, with a three-factor seven-item EPDS model, reflecting anxiety, depression and anhedonia (a reduced ability to feel pleasure) fitting the data best in both datasets. The use of the sub-scale components identified requires further investigation with a range of populations in both research and clinical practice contexts.
BBC Radio 4 - More or Less have interviewed Rachel Rowe (Senior Health Services Researcher) about the statistics around the risks and benfits of home birth. The discussion centres mainly around the Birthplace Cohort Study which was was coordinated from the National Perinatal Epidemiology Unit and will be aired on Friday 01 June 2018 at 16:30. We hope that you will tune in to listen.
The prestigious British Medical Journal (BMJ) have awarded the UK Research Paper of the Year 2018 to the BUMPES trial team. The BMJ Awards, now in its 10th year, showcases excellence and inspirational contributions in healthcare. The paper “Upright versus lying down position in second stage of labour in nulliparous women with low dose epidural: BUMPES randomised controlled trial“, published in the BMJ in October 2017, was winner of the category which recognises new UK-based research which is likely to have a great impact on improving health and healthcare. The trial and writing committee, the Epidural and Position Trial Collaborative led by Professor Peter Brocklehurst, includes the NPEU Clinical Trials Unit director, Edmund Juszczak, senior trials statistician, Pollyanna Hardy, and senior health economist, Oliver Rivero-Arias. Read more.
New research by Yangmei Li, Maria Quigley, Nirupa Dattani, Ron Gray, Hiranthi Jayaweera, Jenny Kurinczuk, Alison Macfarlane, and Jennifer Hollowell describes ethnic variations in infant mortality and explores the contribution of area deprivation, mother’s country of birth, and prematurity to these variations.
Using routine birth and death data on more than 4.6 million singleton live births in England and Wales, 2006-2012, they found that crude infant mortality rates were higher in Pakistani, Black Caribbean, Black African, and Bangladeshi infants (6.92, 6.00, 5.17 and 4.40 per 1,000 live births, respectively vs. 2.87 in White British infants). Adjustment for sociodemographic characteristics changed the results little. Further adjustment for gestational age strongly attenuated the risk in Black Caribbean (odds ratio 1.02, 95% CI 0.89-1.17) and Black African infants (1.17, 1.06-1.29) but not in Pakistani (2.32, 2.15-2.50), Bangladeshi (1.47, 1.28-1.69), and Indian infants (1.24, 1.11-1.38).
These results suggest that higher proportions of very premature infants appear to explain increased risks in Black infants but not in South Asian groups.
Read the research in full in the PLOS ONE journal.
New research by Maria Quigley, Claire Carson and Yvonne Kelly helps shed light on why the association between breastfeeding and childhood wheeze varies in previous studies.
Using data on 10,126 children, they found that the association between breastfeeding and childhood wheeze (in the past year) varies according to the age at which wheezing is assessed. For example, babies who were breastfed for 6-9 months were less likely to experience wheezing at age 9 months, 3, and 5 years, but this ‘protective’ effect was less apparent at age 7 and 11 years (adjusted odds ratios 0.73, 0.78, 0.79, 0.84, 1.06 respectively). The pattern of wheeze throughout childhood can be described as the ‘wheezing phenotype’. Breastfeeding was also associated with a lower odds of an ‘early transient’ phenotype (where the child had wheezing at any age up to 5 years but not thereafter) but not with other wheezing phenotypes such as ‘late onset’ (any time from age 7 but not beforehand) or ‘persistent’ (any time up to age 5 and any time from age 7). These results suggest that the association between breastfeeding and subsequent wheeze varies according to age at which wheezing is assessed, and underlying wheezing phenotype.
Following Professor Juszczak's talk at NeoCARD Conference in October 2017, we are excited to share with you his paper on "Continued uncertainty regarding treatment of patent ductus arteriosus in premature infants and the role of clinical trials"
For more details you can read the full article in Seminar in Fetal and Neonatal Medicine.